October 4, 2023

Photo courtesy of ASHP graphic from Getty Images
Most ACP Hospitalist content is available exclusively to ACP Members. This article is free to the public.

Drug shortages drag on

Almost all hospital pharmacists reported facing drug shortages in a recent survey, but there are some available solutions, one expert says.

New COVID-19 boosters, biosimilar for MS OK’ed

The FDA approved updated COVID-19 vaccines and the first-ever biosimilar for multiple sclerosis (MS), among other recent actions.

Peripheral internal jugular catheters possible solution to difficult IV access

In a two-year pilot study involving 32 eligible patients at a U.S. academic hospital, 97% of peripheral internal jugular catheters were successfully placed with no complications.

Phase 3 trial finds new antibiotic noninferior to daptomycin for MRSA

An industry-funded trial compared ceftobiprole, a cephalosporin, to daptomycin plus optional aztreonam in adults with complicated Staphylococcus aureus bacteremia, including methicillin-resistant S. aureus (MRSA).

Most buprenorphine prescriptions not continued during hospitalization, VA study finds

An analysis of patients who had active buprenorphine prescriptions before a medical or surgical admission to a Veterans Administration (VA) hospital in 2018 to 2020 found that only 74.3% received a prescription for the drug in the 60 days after discharge.

1 in 3 adults with new-onset a fib during hospitalization have recurrence within a year

The findings suggest that patients who experience a transient episode of atrial fibrillation during hospitalization need risk stratification and follow-up, according to the authors of the matched cohort study.